cro.directory
← Compare landing

CRAMSN vs Scinai Immunotherapeutics Ltd.

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/cramsn-research-park/scinai-immunotherapeutics

CategoryCRAMSNScinai Immunotherapeutics Ltd.
Listed sitebothboth
SummaryCRAMSN is a contract research, development, and manufacturing organization (CRO/CDMO/CMO) offering end-to-end solutions for drug substance and drug product development with GMP-certified facilities recognized by US, EU, Japan, and Canada regulatory authorities.Boutique biologics CDMO providing analytical method development, process development, and cGMP manufacturing for biotech clients from early research through Phase 3, backed by over 20 years of experience and state-of-the-art facilities.
Services
  • Process Development
  • CMC Analytical Development
  • Formulation Development
  • Technology Transfer
  • Quality Control Testing
  • Stability Testing & Storage
  • CMC Regulatory Submission Support
  • API Synthesis & Manufacturing
  • Small Molecule Development & Manufacturing
  • CMC Analytical Development
  • Process Development
  • CMC Regulatory Submission Support
  • Technology Transfer
  • Recombinant Protein Manufacturing
  • Biologics Development & Manufacturing
ModalitiesData not yet provided.
  • Biologics (Monoclonal Antibodies)
IndicationsData not yet provided.
  • Dermatology
  • Immunology
  • Rare Disease
Locations
  • FDF Manufacturing Facility, New Jersey, New Jersey, USA
  • Headquarters, Jerusalem, Israel
  • Yavne CDMO Facility, Yavne, Israel
CertificationsData not yet provided.
  • EMA · Identifier: European QP (EMA) audit passed
  • Israeli Ministry of Health · Identifier: Israeli MoH audit passed for Phase 3 clinical trial production
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.